Clinical Trials on Haemophilia B With Inhibitors in China
Total 67 results
-
Suzhou Alphamab Co., Ltd.RecruitingHemophilia A With Inhibitor | Hemophilia B With InhibitorChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownHemophilia A With Inhibitor | Hemophilia B With InhibitorChina
-
Jiangsu Gensciences lnc.RecruitingHemophilia | Hemophilia A With Inhibitor | Male | Hemophilia B With InhibitorChina
-
Jiangsu Gensciences lnc.CompletedFactor VII Deficiency | Hemophilia A With Inhibitor | Hemophilia B With InhibitorChina
-
Novo Nordisk A/SRecruitingHaemophilia A With Inhibitors | Haemophilia AUnited States, Korea, Republic of, France, Spain, Romania, Canada, Taiwan, China, Lithuania, Netherlands, India, South Africa, Russian Federation, Austria, Belgium, Czechia, Denmark, Germany, Ireland, Italy, Japan, Latvia, Malaysia, M... and more
-
Novo Nordisk A/SRecruitingHaemophilia A With Inhibitors | Haemophilia ATaiwan, Canada, Spain, Netherlands, Korea, Republic of, India, United States, United Kingdom, China, Portugal, Lithuania, Turkey, South Africa, Ireland, Italy, France, Japan, Belgium, Malaysia, Poland, Austria, Bulgaria, Denmark, Germany and more
-
Novo Nordisk A/SRecruitingHaemophilia A With or Without InhibitorsIndia, China, Korea, Republic of, Canada, Spain, Netherlands, South Africa, United States, Israel, Poland, United Kingdom, Italy, Japan, Lithuania, Portugal, Switzerland, Taiwan
-
Institute of Hematology & Blood Diseases Hospital...Sinocelltech Ltd.RecruitingHemophilia A With InhibitorChina
-
Beijing Children's HospitalUnknownHemophilia A With InhibitorChina
-
Novo Nordisk A/SEnrolling by invitation
-
Novo Nordisk A/SActive, not recruiting
-
GlaxoSmithKlineCompletedHaemophilus Influenzae Type b DiseaseChina
-
Novartis VaccinesCompletedHaemophilus Influenzae Type b (Hib) InfectionChina
-
Beijing Minhai Biotechnology Co., LtdUnknownHaemophilus Influenzae Type b InfectionsChina
-
Institute of Hematology & Blood Diseases HospitalNot yet recruiting
-
PfizerCompleted
-
Institute of Hematology & Blood Diseases HospitalNot yet recruiting
-
Shanghai Vitalgen BioPharma Co., Ltd.Not yet recruiting
-
Institute of Hematology & Blood Diseases HospitalRecruiting
-
PfizerCompleted
-
Fudan UniversityNot yet recruitingthe Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced MelanomaChina
-
Institute of Hematology & Blood Diseases HospitalEast China University of Science and TechnologyActive, not recruiting
-
Fudan UniversityUnknownNeoplasms | Immune System Diseases | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Gemcitabine | Cisplatin | Dexamethasone | Rituximab | Cyclophosphamide | Chidamide | Neoplasm by Histology | HDAC InhibitorChina
-
Novartis VaccinesCompletedHaemophilus Influenzae Type bChina
-
Jiangsu Province Centers for Disease Control and...Royal (Wuxi) Biological Co., LTDCompletedGroup A, C Polysaccharide Meningitis | Type b Haemophilus InfluenzaChina
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
BayerCompletedHemophilia A, Hemophilia BItaly, China, New Zealand, Russian Federation, Taiwan, Singapore, Bulgaria, United States, Denmark, Germany, Hungary, South Africa, United Kingdom, Romania, Colombia, Mexico, Turkey, France, India, Japan, Australia, Netherlands, Poland and more
-
Novartis VaccinesCompletedHaemophilus Influenzae Type bChina
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia BSweden, United States, France, Italy, Russian Federation, United Kingdom, Germany, China, Poland, Japan, Australia, Brazil, Canada, India, South Africa, Hong Kong, Belgium
-
Novartis VaccinesCompletedHaemophilus Influenzae Type b (Hib) InfectionChina
-
The University of Hong KongResearch Grant CouncilRecruitingCirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 InhibitorsHong Kong
-
Novartis VaccinesCompletedHaemophilus Influenzae Type b (Hib) InfectionChina
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia BUnited States, Italy, Belgium, Australia, Brazil, Hong Kong, India, Ireland, Japan, South Africa, United Kingdom, Netherlands, Sweden, Canada, Poland, China, France, Germany
-
Chinese PLA General HospitalRecruitingPD-1 Inhibitor Failed Patients With Classical Hodgkin LymphomaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingHemophilia A | Hemophilia BChina
-
Shanghai Belief-Delivery BioMed Co., LtdActive, not recruiting
-
Fujian Medical UniversityRecruitingRelapsed or Refractory DLBCL Patients With Either CD19 or CD20 PositiveChina
-
The 458 Hospital of Chinese PLAGuangzhou Baidi Biotechnology Co., Ltd; Guangzhou Pharmaceucal Company LimitedUnknownChronic Hepatitis B Patients With HBeAg-positiveChina
-
GlaxoSmithKlineCompletedTetanus | Diphtheria | Acellular Pertussis | Haemophilus Influenzae Type bChina
-
GlaxoSmithKlineCompletedTetanus | Diphtheria | Acellular Pertussis | Haemophilus Influenzae Type bChina
-
Shandong Provincial HospitalRecruitingMantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsChina
-
Shandong Provincial HospitalRecruitingMantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | B-cell NonHodgkin LymphomaChina
-
Sun Yat-sen UniversityNot yet recruitingImmune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular CarcinomaChina
-
Samsung Medical CenterCompletedPatients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma | Patients Treated With Rituximab-CHOP or Rituximab-CVPKorea, Republic of, Malaysia, Singapore, China
-
Jinan University GuangzhouGuagnzhou Qiaokang HospitalUnknownAdoptive Treatment for Hepatitis B With γδT CellsChina
-
Genzyme, a Sanofi CompanyCompletedHemophilia A | Hemophilia BUnited States, Australia, Canada, China, France, Korea, Republic of, Malaysia, Turkey, Ukraine, United Kingdom, Germany, India, Italy, Japan, South Africa, Spain, Taiwan
-
Genzyme, a Sanofi CompanyCompletedHemophilia A | Hemophilia BUnited States, Australia, China, Denmark, France, Israel, Japan, Korea, Republic of, Malaysia, Turkey, Ukraine, United Kingdom, Germany, India, South Africa, Spain, Taiwan, Hungary, Italy
-
PfizerRecruitingHemophilia A | Hemophilia BHong Kong, Spain, Serbia, Turkey, United States, China, Mexico, South Africa, India, Japan, Croatia, Korea, Republic of, Oman, Taiwan, Italy, Canada, France
-
Rong TaoNovatim Immune Therapeutics (Zhejiang) Co., Ltd.RecruitingAcute Lymphoblastic Leukemia, in Relapse | B-cell Lymphoma Refractory | B-cell Lymphoma Recurrent | Acute Lymphoblastic Leukemia With Failed RemissionChina
-
Fuzhou General HospitalRecruitingChronic Hepatitis B Patients With a Normal ALT Level and Low ViremiaChina